PAUZA CHARLES DAVID (Chief Science Officer Virology) received a stock award from TRAWS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2024ACC: 0000929638-24-001364
Officer· Chief Science Officer Virology
Since Mar 2026
+933.86K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
933.86K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+97.50K
Price / share
—
Trade value
—
% of position
New position
4/1/2024
0.00→97.50K
Total
Net shares
+97.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | A · Award | +97.50K | — | — | New position | 0.00 | 97.50K |
| Total | +97.50K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to purchase)
Direct
Converts to
Common Stock
333.14K shares
Shares
+333.14K
Strike price
0.07
Held after
333.14K
Exercisable
—
4/1/2024
Stock Option (right to purchase)
Direct
Converts to
Common Stock
503.23K shares
Shares
+503.23K
Strike price
0.01
Held after
503.23K
Exercisable
—
4/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase) Direct | Common Stock333.14K shares | 4/1/2024 | A · Award | +333.14K | 0.07 | — | 333.14K |
| Stock Option (right to purchase) Direct | Common Stock503.23K shares | 4/1/2024 | A · Award | +503.23K | 0.01 | — | 503.23K |